Testing urine for drugs.

[1]  D. Moriarty,et al.  The Canadian Commission of Inquiry into the Use of Drugs and Banned Practices Intended to Increase Athletic Performance , 1991 .

[2]  S. Belknap,et al.  Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. , 1988, Journal of analytical toxicology.

[3]  K. Ash,et al.  Adulterants causing false negatives in illicit drug testing. , 1988, Clinical chemistry.

[4]  R V Blanke,et al.  Assessment of laboratory quality in urine drug testing. A proficiency testing pilot study. , 1988, JAMA.

[5]  D. Gokhale,et al.  Confirmation and certainty in toxicology screening. , 1988, Clinical chemistry.

[6]  S. Mulé,et al.  Rendering the "poppy-seed defense" defenseless: identification of 6-monoacetylmorphine in urine by gas chromatography/mass spectroscopy. , 1988, Clinical chemistry.

[7]  J. Irving.  Drug testing in the military--technical and legal problems. , 1988, Clinical chemistry.

[8]  R. Chamberlain.  Legal issues related to drug testing in the clinical laboratory. , 1988, Clinical chemistry.

[9]  H. Ruf,et al.  Interaction of stanozolol with cytochrome P-450. , 1988, Biochemical pharmacology.

[10]  D. Catlin,et al.  Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984. , 1987, Clinical chemistry.

[11]  A. Astrup,et al.  Tissue/blood partition coefficients for xenon in various adipose tissue depots in man. , 1987, Scandinavian journal of clinical and laboratory investigation.

[12]  E. Cone,et al.  Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke , 1986, Clinical pharmacology and therapeutics.

[13]  M. Debackere,et al.  The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. , 1986, Arzneimittel-Forschung.

[14]  M W Fischman,et al.  Kinetics of cocaine distribution, elimination, and chronotropic effects , 1985, Clinical pharmacology and therapeutics.

[15]  S. Caudill,et al.  Crisis in drug testing. Results of CDC blind study. , 1985, JAMA.

[16]  L. J. King,et al.  Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin , 1984, The Journal of pharmacy and pharmacology.

[17]  B. Sadler,et al.  Metabolism, disposition, and kinetics of delta‐9‐tetrahydrocannabinol in men and women , 1983, Clinical pharmacology and therapeutics.

[18]  H. Ruf,et al.  Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[19]  A. Nilsson,et al.  Morphine intake from poppy seed food , 1982 .

[20]  M. Wheeler,et al.  Detection of anabolic steroid administration to athletes. , 1979, Journal of steroid biochemistry.

[21]  J. Salmon,et al.  The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [14C]amphetamine , 1969, The Journal of pharmacy and pharmacology.

[22]  荒井保明.  Pharmacokinetics , 1993 .

[23]  M. B. Evans,et al.  Recent developments in the gas chromatographic retention index scheme , 1989 .

[24]  R. Massé,et al.  STUDIES OF ANABOLIC STEROIDS , 1989 .

[25]  Critical issues in urinalysis of abused substances: report of the Substance-Abuse Testing Committee. , 1988, Clinical chemistry.

[26]  A. Uldall.  Quality assurance in clinical chemistry. , 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[27]  M. Murray,et al.  Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents. , 1987, Drug metabolism reviews.

[28]  Willette Re.  Drug testing programs. , 1986 .

[29]  M. Debackere,et al.  The influence of diuretics on the excretion and metabolism of doping agents. II. Phentermine. , 1986, Arzneimittel-Forschung.

[30]  R. Willette.  Drug testing programs. , 1986, NIDA research monograph.

[31]  R. Hawks.  Analytical methodology. , 1986, NIDA research monograph.

[32]  R. Bastiani.  URINARY CANNABINOID EXCRETION PATTERNS , 1984 .

[33]  E. Kováts,et al.  Gas‐chromatographische Charakterisierung organischer Verbindungen. Teil 1: Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone , 1958 .

[34]  D. Bush.  Department of Health and Human Services Substance Abuse and Mental Health Services Administration Mandatory Guidelines for Federal Workplace Drug Testing Programs , 2022 .